Antiviral target compound profile for pandemic preparedness
- PMID: 39622985
- DOI: 10.1038/s41573-024-01102-3
Antiviral target compound profile for pandemic preparedness
Conflict of interest statement
Competing interests: T.C., J.P.B., and Y.M. are employees of Gilead Sciences. K.B., J.A.T.Y., A.C.H., and T.T. are employees of F. Hoffmann-LaRoche. R.C. and S.V. are employees of Novartis Pharmaceuticals. C.L.L and A.C. are employees of AbbVie. M.v.L. is an employee of Janssen Pharmaceutica. J.F.D., R.D.-A., K.S.S., M.C.-M., L.R., R.M., N.M.H, and J.C.P. declare no competing interests.
References
-
- von Delft, A. et al. Accelerating antiviral drug discovery: lessons from COVID-19. Nat. Rev. Drug Discov. 22, 585–603 (2023). - DOI
-
- Guidance for Industry and Review Staff: Target Product Profile — A Strategic Development Process Tool (US Food & Drug Administration, 2007); https://fda.report/media/72566/Target-Product-Profile----A-Strategic-Development-Process-Tool.pdf .
-
- Target Product Profiles for Antivirals (National Institute of Allergy and Infectious Disease, 2024); https://www.niaid.nih.gov/research/target-product-profiles-antivirals .
-
- Target product profiles. Drugs for Neglected Diseases Initiative (2024); https://dndi.org/research-and-development/target-product-profiles/ .
-
- Links to WHO target product profiles (TPPs) and product profile characteristics (PPCs). World Health Organization (2024); https://www.who.int/observatories/global-observatory-on-health-research-... .
Publication types
LinkOut - more resources
Full Text Sources